XML 45 R32.htm IDEA: XBRL DOCUMENT v3.8.0.1
Business Combination - Summary of Unaudited Pro Forma Information (Detail) - PharmAthene [Member] - USD ($)
9 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Business Acquisition [Line Items]    
Pro forma revenue and grants and contracts $ 9,035,435 $ 6,262,748
Pro forma net (loss) income attributable to common stockholders $ (39,277,568) $ 111,784,503
Pro forma weighted average common shares outstanding, basic 15,218,542 14,268,717
Pro forma net (loss) income per share, basic $ (2.58) $ 7.83
Pro forma weighted average common shares outstanding, diluted 15,218,542 15,107,312
Pro forma net (loss) income per share, diluted $ (2.58) $ 7.40